Danger: High levels of hospital bed occupancy rates in England
Taken directly from BMJ news Overall, 83.8% of the 123 707 beds available overnight were occupied between April and June this year, show bed occupancy rates…
View More Danger: High levels of hospital bed occupancy rates in England
Reducing barriers to MRI in patients with CIEDs
Taken directly from European Heart Journal Many cardiac pacemakers and defibrillators are not approved by regulators for magnetic resonance imaging (MRI) which makes patient access…
View More Reducing barriers to MRI in patients with CIEDs
Percutaneous Coronary Revascularisation: Historical Breakthroughs
Taken directly from JACC Over the last 4 decades, percutaneous coronary intervention has evolved dramatically and is now an acceptable treatment option for patients with…
View More Percutaneous Coronary Revascularisation: Historical Breakthroughs
Highlights from Day 2 of the ESC 2021 congress – APAF-CRT
By Ahmed El-Medany Presented by Professor Michele Brignole, San Luca Hospital, Milan, APAF-CRT was a two-phase trial in individuals with severely symptomatic atrial fibrillation (AF)…
View More Highlights from Day 2 of the ESC 2021 congress – APAF-CRT
Highlights from Day 2 of the ESC 2021 congress – ENVISAGE-TAVI AF
The ENVISAGE-TAVI AF trial demonstrated that Edoxaban’s non-inferiority to warfarin with regards to myocardial infarction (MI), ischaemic stroke, systemic thromboembolism, and valve thrombosis, in participants…
View More Highlights from Day 2 of the ESC 2021 congress – ENVISAGE-TAVI AF
Highlights from Day 2 of the ESC 2021 congress – MASTER DAPT
Presented by Dr. Marco Valgimigli, the MASTER DAPT trial assessed whether 1 month of dual antiplatelet therapy (DAPT) following percutaneous coronary intervention (PCI), with a…
View More Highlights from Day 2 of the ESC 2021 congress – MASTER DAPT
Highlights from Day 1 of the ESC congress – SMART-MI
By Ahmed El-Medany As usual, there were a multitude of fascinating trials presented at the Hot Line session at the ESC Congress 2021. Professor Axel…
View More Highlights from Day 1 of the ESC congress – SMART-MI
New approaches to Lipid management
New agreement between Novartis and the NHS enables broad and rapid access to cholestrol lowering medicine ‘Inclisiran’. In December 2019, an in-principle agreement was made…
View More New approaches to Lipid management
New 2021 ESC Guidelines for the diagnosis and management of heart failure published
By Ahmed El-Medany The 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure (HF) were published on the 27th of…
View More New 2021 ESC Guidelines for the diagnosis and management of heart failure published
Impaired retinal microvascular function predicts long-term adverse events in patients with cardiovascular disease
By Theuerle JD, Al-Fiadh AH et al Endothelial dysfunction is a precursor to the development of symptomatic atherosclerosis. Retinal microvascular reactivity to flicker light stimulation…
View More Impaired retinal microvascular function predicts long-term adverse events in patients with cardiovascular disease